Allgens Medical Technology Co. Ltd. A
Allgens Medical Technology CO., LTD. engages in the research and development, production, and sale of biomedical materials and related medical device products in China. The company offers collagen artificial bone repair materials to agents and terminal hospitals. Its products include Tooth Shell for the treatment of oral or plastic surgery and BonGold for the treatment of orthopedic bone defect r… Read more
Allgens Medical Technology Co. Ltd. A (688613) - Total Assets
Latest total assets as of September 2025: CN¥1.54 Billion CNY
Based on the latest financial reports, Allgens Medical Technology Co. Ltd. A (688613) holds total assets worth CN¥1.54 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Allgens Medical Technology Co. Ltd. A - Total Assets Trend (2017–2024)
This chart illustrates how Allgens Medical Technology Co. Ltd. A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Allgens Medical Technology Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Allgens Medical Technology Co. Ltd. A's total assets of CN¥1.54 Billion consist of 77.7% current assets and 22.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.2% |
| Accounts Receivable | CN¥77.25 Million | 5.0% |
| Inventory | CN¥54.58 Million | 3.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥25.36 Million | 1.7% |
| Goodwill | CN¥24.62 Million | 1.6% |
Asset Composition Trend (2017–2024)
This chart illustrates how Allgens Medical Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allgens Medical Technology Co. Ltd. A's current assets represent 77.7% of total assets in 2024, a decrease from 80.5% in 2017.
- Cash Position: Cash and equivalents constituted 10.2% of total assets in 2024, up from 4.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, unchanged from 2.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 5.0% of total assets.
Allgens Medical Technology Co. Ltd. A Competitors by Total Assets
Key competitors of Allgens Medical Technology Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Allgens Medical Technology Co. Ltd. A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Allgens Medical Technology Co. Ltd. A generates 0.13x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Allgens Medical Technology Co. Ltd. A is currently not profitable relative to its asset base.
Allgens Medical Technology Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.88 | 25.10 | 7.77 |
| Quick Ratio | 16.62 | 24.27 | 7.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.15 Billion | CN¥ 1.16 Billion | CN¥ 483.08 Million |
Allgens Medical Technology Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Allgens Medical Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.29 |
| Latest Market Cap to Assets Ratio | 0.20 |
| Asset Growth Rate (YoY) | 0.8% |
| Total Assets | CN¥1.54 Billion |
| Market Capitalization | $310.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Allgens Medical Technology Co. Ltd. A's assets below their book value (0.20 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Allgens Medical Technology Co. Ltd. A's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Allgens Medical Technology Co. Ltd. A (2017–2024)
The table below shows the annual total assets of Allgens Medical Technology Co. Ltd. A from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.54 Billion | +0.85% |
| 2023-12-31 | CN¥1.53 Billion | +4.59% |
| 2022-12-31 | CN¥1.46 Billion | +2.32% |
| 2021-12-31 | CN¥1.43 Billion | +77.17% |
| 2020-12-31 | CN¥804.93 Million | +12.41% |
| 2019-12-31 | CN¥716.08 Million | +36.37% |
| 2018-12-31 | CN¥525.10 Million | +63.85% |
| 2017-12-31 | CN¥320.47 Million | -- |